Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BJCT-BIOJECT-needle less injection product -- Ignore unavailable to you. Want to Upgrade?

To: geewiz who wrote (136)	3/27/1998 4:00:00 PM
From: Sam	Read Replies (1) \| Respond to of 534

CFO resigns: biz.yahoo.com

To: geewiz who wrote (136)	4/14/1998 9:25:00 PM
From: Ron Coby	Respond to of 534

Elan is no way selling bjct.They're looking at bjct like dura.These guys are looking for a big hit here.If anything elan may add but not sell.I hear that lly(eli lilly)has a piece and some hedge fund selling out but stocks under massive accumulation here and ready to break-out on the stock charts.These guys are going to r.i.b.a. meeting next week to tell about the exciting things that are going on at the company.There will be 200 brokers at that meeting.The company would like the stock at 3 to get remaining warrants converted and they'll be telling their story for the first time in a very long time to the investment community.Some very large wall street stategist looking at covering bjct for the gluclose monitoring device which would take the stock to the companys desired levels.